TapewireFind a company

person · Reporting owner

ANDERSON KERRII B

Disclosed activity across 4 companies

Tapewire entity
22515
SEC CIK
0001227159

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ABERCROMBIE & FITCH CO /DE/ANF · Entity 3771DirectorAugust 03, 2026August 04, 2026
LABCORP HOLDINGS INC.LH · Entity 1277DirectorAugust 17, 2026August 18, 2026
SHERWIN WILLIAMS COSHW · Entity 2948DirectorOctober 02, 2026October 06, 2026
WORTHINGTON ENTERPRISES, INC.WOR · Entity 4282DirectorSeptember 23, 2025September 25, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ABERCROMBIE & FITCH CO /DE/

Report date August 03, 2026 · Filed August 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect4,220.522 Reported balance After 2026-08-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-08-03 · Grant · Acquired 91.044 · Balance 4,220.522

F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

LABCORP HOLDINGS INC.

Report date August 17, 2026 · Filed August 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect6,563 Reported balance After 2026-08-17 transaction · row 1
1 source row

Row 1 · 2026-08-17 · Sale · Disposed 3,000 · Balance 6,563

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Common StockSEC Table I · non-derivativeIndirectBy Alexa M. Anderson Separate Trust144 Reported balance Holding disclosure · report date 2026-08-17 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 144

Common StockSEC Table I · non-derivativeIndirectBy Cameron Taff Anderson Separate Trust144 Reported balance Holding disclosure · report date 2026-08-17 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 144

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SHERWIN WILLIAMS CO

Report date October 02, 2026 · Filed October 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectDeferred Fee Plan1,109.95 Reported balance After 2026-10-02 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-10-02 · Grant · Acquired 30.85 · Balance 1,109.95

F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Common StockSEC Table I · non-derivativeDirect5,819 Reported balance Holding disclosure · report date 2026-10-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 5,819

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

F4: No transaction is being reported on this line. Reported on a previously filed Form 4.

F5: These securities consist of 1,100 restricted stock units ("RSUs") and 4,719 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

WORTHINGTON ENTERPRISES, INC.

Report date September 23, 2025 · Filed September 25, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect76,659 Reported balance After 2026-09-24 transaction · row 1
1 source row

Row 1 · 2026-09-24 · Grant · Acquired 2,510 · Balance 76,659

F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

Phantom StockSEC Table II · derivative / convertible securityDirect12,822.05 Reported balance After 2026-09-23 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-23 · Grant · Acquired 192.63 · Balance 12,822.05

F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.

Common SharesSEC Table I · non-derivativeIndirectBy Cameron Taff Anderson Separate Trust1,421 Reported balance Holding disclosure · report date 2025-09-23 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,421

Common SharesSEC Table I · non-derivativeIndirectBy Alexa M. Anderson Separate Trust1,421 Reported balance Holding disclosure · report date 2025-09-23 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 1,421

Common SharesSEC Table I · non-derivativeIndirectBy spouse436 Reported balance Holding disclosure · report date 2025-09-23 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 436

Filing footnotes · ownership attribution and instrument terms

F1: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

F2: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F3: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F4: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 02, 2026 Filed Oct 6, 2026 22:05 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 30.85 $324.14 $9,999.72
Disclosure

SEC source: 0001227159-26-000012 · wk-form4_1791324342.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 1,109.95

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
September 24, 2026 Filed Sep 25, 2026 14:28 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 2,510 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-401855 · ownership.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,659

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

Read SEC document
September 23, 2026 Filed Sep 25, 2026 14:28 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 192.63 $59.70 $11,500.01
Disclosure

SEC source: 0001193125-26-401855 · ownership.xml · derivative · entry 5

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,822.05

Underlying: Common Shares · 192.63 shares

Expires not disclosed

F2 · derivative.exercise_price: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F3 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F3 · derivative.expiration_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F4 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 24, 2025.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 12:10 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 3,000 $318.02 $954,060.00
Disclosure

SEC source: 0000920148-26-000186 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,563

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
August 03, 2026 Filed Aug 4, 2026 20:15 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 91.044 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-006927 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,220.522

Underlying: Class A Common Stock · 91.044 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
July 06, 2026 Filed Jul 8, 2026 17:21 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 28.54 $350.40 $10,000.42
Disclosure

SEC source: 0001227159-26-000010 · wk-form4_1783531279.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 1,076.42

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionRestricted Stock Unit · Derivative 2,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005854 · doc4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,160

Underlying: Class A Common Stock · 2,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F4 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantRestricted Stock Unit · Derivative 2,160 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005854 · doc4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,249

Underlying: Class A Common Stock · 2,160 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F4 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F4 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionPhantom Stock · Derivative 522 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005854 · doc4.xml · derivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,129.478

Underlying: Class A Common Stock · 522 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionClass A Common Stock 1,567 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005854 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2026 Filed May 12, 2026 21:03 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 107.198 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005173 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,607.478

Underlying: Class A Common Stock · 107.198 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 21:07 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 31.7 $315.50 $10,001.35
Disclosure

SEC source: 0001227159-26-000008 · wk-form4_1775682466.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 1,045.15

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
February 17, 2026 Filed Feb 17, 2026 23:05 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 558 $0.00 $0.00
Disclosure

SEC source: 0001227159-26-000004 · wk-form4_1771369542.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,819

F1 · shares: Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.

F2 · balance_after: These securities consist of 1,100 RSUs and 4,719 shares of Common Stock.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:47 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 897 $0.00 $0.00
Disclosure

SEC source: 0000920148-26-000071 · form4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 773

Underlying: Common Stock · 897 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 11, 2026.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 11, 2026.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 17:47 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 897 Not disclosed Not disclosed
Disclosure

SEC source: 0000920148-26-000071 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 15:59 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 773 $0.00 $0.00
Disclosure

SEC source: 0000920148-26-000041 · form4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,670

Underlying: Common Stock · 773 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 10, 2027.

F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 10, 2027.

F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:52 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 92.825 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-001315 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,500.28

Underlying: Class A Common Stock · 92.825 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
January 09, 2026 Filed Jan 13, 2026 23:03 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 28.94 $345.60 $10,001.66
Disclosure

SEC source: 0001227159-26-000002 · wk-form4_1768345432.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 1,010.94

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
November 03, 2025 Filed Nov 4, 2025 21:18 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 124.914 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-008913 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,407.455

Underlying: Class A Common Stock · 124.914 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F3 · balance_after: Total includes accrued dividends.

Read SEC document
October 03, 2025 Filed Oct 7, 2025 20:06 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 29.09 $343.81 $10,001.43
Disclosure

SEC source: 0001227159-25-000006 · wk-form4_1759867601.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 979.69

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
September 25, 2025 Filed Sep 26, 2025 15:38 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 2,815 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-219805 · ownership.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,149

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

Read SEC document
September 23, 2025 Filed Sep 24, 2025 14:25 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 286.26 $60.26 $17,250.03
Disclosure

SEC source: 0001193125-25-214443 · ownership.xml · derivative · entry 5

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,450.26

Underlying: Common Shares · 286.26 shares

Expires not disclosed

F1 · derivative.exercise_price: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F2 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F2 · derivative.expiration_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F3 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on September 30, 2024.

Read SEC document
August 29, 2025 Filed Sep 3, 2025 21:08 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 SaleClass A Common Stock 4,292 $95.12 $408,234.44
Disclosure

SEC source: 0001225208-25-007732 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,158

F1 · price: Price represents a weighted average of the sale price. Shares were sold at prices ranging from $94.83 to $95.42. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.

Read SEC document
August 04, 2025 Filed Aug 5, 2025 21:01 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 99.522 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-007041 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,282.541

Underlying: Class A Common Stock · 99.522 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
July 24, 2025 Filed Jul 28, 2025 19:59 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 3,500 $280.00 $980,000.00
Disclosure

SEC source: 0001127602-25-019628 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,666

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
July 24, 2025 Filed Jul 28, 2025 19:59 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 3,500 $280.00 $980,000.00
Disclosure

SEC source: 0001127602-25-019625 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,666

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
July 07, 2025 Filed Jul 9, 2025 20:37 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 28.86 $346.53 $10,000.86
Disclosure

SEC source: 0000089800-25-000106 · wk-form4_1752093434.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 948.59

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
July 01, 2025 Filed Jul 2, 2025 14:37 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 500 $265.00 $132,500.00
Disclosure

SEC source: 0001127602-25-018440 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,166

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 14:07 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 500 $260.00 $130,000.00
Disclosure

SEC source: 0001127602-25-017341 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,666

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:46 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionRestricted Stock Unit · Derivative 780 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005949 · doc4.xml · derivative · entry 3

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,089

Underlying: Class A Common Stock · 780 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:46 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantRestricted Stock Unit · Derivative 2,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005949 · doc4.xml · derivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,869

Underlying: Class A Common Stock · 2,089 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:46 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 Exercise / conversionClass A Common Stock 780 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-005949 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2025 Filed May 7, 2025 20:13 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantPhantom Stock · Derivative 128.019 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-004823 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,183.019

Underlying: Class A Common Stock · 128.019 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of Common Stock of the Issuer upon the reporting person's termination of service as a director.

Read SEC document
April 04, 2025 Filed Apr 7, 2025 20:37 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 29.56 $338.25 $9,998.67
Disclosure

SEC source: 0000089800-25-000062 · wk-form4_1744058224.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 917.73

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 13:16 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 500 $255.63 $127,817.35
Disclosure

SEC source: 0001127602-25-008647 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,166

Read SEC document
February 18, 2025 Filed Feb 20, 2025 22:04 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 517 $0.00 $0.00
Disclosure

SEC source: 0000089800-25-000018 · wk-form4_1740089063.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,261

F1 · shares: Grant of restricted stock units ("RSUs") under The Sherwin-Williams Company 2006 Stock Plan for Nonemployee Directors.

F2 · balance_after: These securities consist of 1,150 RSUs and 4,111 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

Read SEC document
February 11, 2025 Filed Feb 13, 2025 13:19 UTC LABCORP HOLDINGS INC. LH · Entity 1277 GrantRestricted Stock Unit · Derivative 897 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-004514 · form4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 897

Underlying: Common Stock · 897 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vest fully on February 11, 2026.

F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 11, 2026.

Read SEC document
February 06, 2025 Filed Feb 10, 2025 13:40 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionRestricted Stock Unit · Derivative 944 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-003702 · form4.xml · derivative · entry 4

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 944 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 6, 2025.

F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 6, 2025.

Read SEC document
February 06, 2025 Filed Feb 10, 2025 13:40 UTC LABCORP HOLDINGS INC. LH · Entity 1277 Exercise / conversionCommon Stock 944 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-25-003702 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

Read SEC document
January 07, 2025 Filed Jan 8, 2025 16:15 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 1,000 $235.00 $235,000.00
Disclosure

SEC source: 0001127602-25-000986 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,722

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
January 03, 2025 Filed Jan 8, 2025 00:08 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 29.85 $335.00 $9,999.75
Disclosure

SEC source: 0000089800-25-000002 · wk-form4_1736294917.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 886.12

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
December 03, 2024 Filed Dec 4, 2024 21:53 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GiftClass A Common Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010534 · doc4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,670

Read SEC document
October 24, 2024 Filed Oct 25, 2024 13:26 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 1,000 $230.00 $230,000.00
Disclosure

SEC source: 0001127602-24-025961 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,722

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
October 04, 2024 Filed Oct 8, 2024 21:58 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 26.85 $372.47 $10,000.82
Disclosure

SEC source: 0000089800-24-000124 · wk-form4_1728424714.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 854.69

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
September 27, 2024 Filed Sep 30, 2024 14:09 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantPhantom Stock · Derivative 563.31 $40.83 $22,999.95
Disclosure

SEC source: 0000950170-24-110188 · ownership.xml · derivative · entry 5

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,040.63

Underlying: Common Shares · 563.31 shares

Expires not disclosed

F1 · derivative.exercise_price: The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

F2 · derivative.exercise_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F2 · derivative.expiration_date: Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan. Distributions are made only in WOR common shares and generally commence upon leaving the Board of Directors of Worthington Enterprises, Inc.

F3 · balance_after: Holdings that were previously reported on Form 4 have been adjusted in connection with the Spin-Off of Worthington Steel, Inc. by the Issuer.

F4 · balance_after: The amount shown reflects additional theoretical common shares (i.e., phantom stock) which were credited pursuant to the dividend reinvestment feature of the 2005 Director Deferred Compensation Plan since the date on which the amount of theoretical common shares credited pursuant to the dividend reinvestment feature under the 2005 Director Deferred Compensation Plan was last updated in the reporting person's Form 4 filed on October 4, 2021.

Read SEC document
September 26, 2024 Filed Sep 27, 2024 13:29 UTC WORTHINGTON ENTERPRISES, INC. WOR · Entity 4282 GrantCommon Shares 3,300 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-109761 · ownership.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,334

F1 · shares: An award of restricted stock was granted pursuant to the Worthington Industries, Inc. Amended and Restated 2006 Equity Incentive Plan for Non-Employee Directors. The restricted stock will vest on the earlier to occur of (1) the first anniversary of the grant date; or (2) the date on which the next Annual Meeting of Shareholders of Worthington Enterprises, Inc. is held.

F2 · balance_after: Holdings that were previously reported on Form 4 have been adjusted in connection with the Spin-Off of Worthington Steel, Inc. by the Issuer.

Read SEC document
August 08, 2024 Filed Aug 9, 2024 14:16 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 586 $225.00 $131,850.00
Disclosure

SEC source: 0001127602-24-021913 · form4.xml · nonDerivative · entry 2

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,722

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 14:16 UTC LABCORP HOLDINGS INC. LH · Entity 1277 SaleCommon Stock 414 $225.00 $93,150.00
Disclosure

SEC source: 0001127602-24-021913 · form4.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,308

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Read SEC document
July 05, 2024 Filed Jul 9, 2024 21:11 UTC SHERWIN WILLIAMS CO SHW · Entity 2948 GrantCommon Stock 33.84 $295.50 $9,999.72
Disclosure

SEC source: 0000089800-24-000099 · wk-form4_1720559495.xml · nonDerivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Deferred Fee Plan

Disclosed balance after: 826.22

F1 · shares: Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

F2 · price: Represents the weighted average share price on the transaction date used to determine the number of deferred stock units to be credited to the Reporting Person's account.

F3 · balance_after: These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:44 UTC ABERCROMBIE & FITCH CO /DE/ ANF · Entity 3771 GrantRestricted Stock Unit · Derivative 780 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-006858 · doc4.xml · derivative · entry 1

ANDERSON KERRII B · CIK 0001227159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 780

Underlying: Class A Common Stock · 780 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

F2 · derivative.expiration_date: Vests the earlier of the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.